Prediction and prevention of type 1 diabetes mellitus: Initial results and recent prospects;Az 1-es típusú diabetes mellitus predikciója és prevenciója: kezdeti eredmények-újabb lehetoségek

Orvosi Hetilap

Volumn 152, Issue 48, 2011, Pages 1916-1921

  Madácsy, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

clinical trials; prediction; prevention; type 1 diabetes

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CELL DAMAGE; CHILDHOOD; DIABETES MELLITUS; DISEASE MARKER; FAMILY HISTORY; GENETIC MARKER; HUMAN; INCIDENCE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREDICTION; PREVALENCE; PRIMARY PREVENTION; REHABILITATION; SECONDARY PREVENTION;

AUTOANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INSULIN; INSULIN-SECRETING CELLS; NIACIN; PREDIABETIC STATE; PREVALENCE; PRIMARY PREVENTION; SECONDARY PREVENTION; TERTIARY PREVENTION; ULTRAVIOLET RAYS; VITAMIN D; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 80955131361     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29246     Document Type: Article

References (39)

1. Madácsy L.: A gyermekkori diabetes mellitus. In: Diabetes melli-tus. Elmélet és klinikum. (Szerk.: Halmos T., Jermendy G. Me-dicina Könyvkiadó, Budapest, 2002, 633-641.
2. Soltész, G., Madácsy, L., Békefi, D. és mtsa: Rising incidence of type 1 diabetes in Hungarian children (1978-1987). Diabet. Med., 1990, 7, 111-114. (Pubitemid 20047209)
3. Gyürüs, É., Green, A., Soltész, G. és mtsai: Dynamic changes in the trends in incidence of type 1 diabetes in children in Hungary (1978-98). Pediatr. Diabetes, 2002, 3, 194-199. (Pubitemid 36024622)
4. Skyler, J. S., Marks, J. B.: Immune intervention in type 1 diabetes mellitus. Diabetes Reviews, 1993, 1, 15-42.
5. American Diabetes Association ad hoc Expert Committee: Prevention of type 1 diabetes mellitus. Diabetes, 1990, 39, 1151-1152.
6. Zhang, L., Eisenbarth, G. S.: Prediction and prevention of type 1 diabetes mellitus. J. Diabetes, 2011, 3, 48-57.
7. Lukács K., Herman R.: Az 1-es típusú diabétesz genetikai háttere, pathogenesise és a legújabb prevenciós kutatások státusza. Gyer-mekgyógyászati Továbbképzo Szemle, 2007, 12, 51-62.
8. Knip, M.: Prediction and prevention of type 1 diabetes. Acta Paediatr. Suppl., 1998, 425, 54-62. (Pubitemid 28478152)
9. Wherett, D. K., Daneman, D.: Prevention of type 1 diabetes. Endocrinol. Metab. Clin. North Am., 2009, 38, 777-790.
10. Thrower, S. L., Bingley, P. J.: Prevention of type 1 diabetes. Br. Med. Bull., 2011, 99, 73-88.
11. Wenzlau, J. M., Juhl, K., Yu, L. és mtsai: The caution efflux transporter ZnT8 is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17040-17045. (Pubitemid 350210987)
12. Madácsy L.: Az 1-es típusú diabetes mellitus prevenciója. In: Diabetes mellitus. Elmélet és klinikum. (Szerk.: Halmos T., Jer-mendy G.) Medicina Könyvkiadó, Budapest, 2002, 731-738.
13. Cernea, S., Dobreanu, M., Raz, I.: Prevention of type 1 diabetes: today and tomorrow. Diabetes Metab. Res. Rev. 2010, 26, 602-605.
14. Akerblom, H. K., Virtanen, S. M., Ilonen, J. és mtsai: Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes. Diabetologia, 2005, 48, 829-837. (Pubitemid 40767974)
15. Bortell, R., Pino, S. C., Greiner, D. L. és mtsai: Closing the circle between the bedside and the banch: Toll-like receptors in models of virally induced diabetes. Ann. N.Y. Acad. Sci., 2008, 1150, 112-122.
16. Akerblom, H. K., Vaarala, O., Hyöty, H. és mtsai: Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet., 2002, 115, 18-29. (Pubitemid 34657185)
17. Badenhoop, K.: Solar power to prevent type 1 diabetes? Pediatr. Diabetes, 2008, 9, 79-80. (Pubitemid 351560355)
18. Virtanen, S. M., Knip, M.: Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am. J. Clin. Nutr., 2003, 78, 1053-1067. (Pubitemid 40003749)
19. Sloka, S., Grant, M., Newhook, L. A: Time series analysis of ultraviolet B radiation and type 1 diabetes in New Fundland. Pediatric Diabetes, 2008, 9, 81-86. (Pubitemid 351560356)
20. Wicklow, B. A., Taback, S. P.: Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk. Ann. N. Y. Acad. Sci., 2006, 1079, 310-312. (Pubitemid 44968739)
21. Knip, M.: Személyes közlés. 2008.
22. Elliott, R. B., Chase, H. P.: Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Dia-betologia, 1991, 34, 362-365
23. The European Nicotinamide Intervention Trial (ENDIT) Group: Intervening before the onset of type 1 diabetes: baseline data of the European Nicotinamide Intervention Trial (ENDIT). Dia-betologia, 2003, 46, 339-346.
24. The European Nicotinamide Intervention Trial (ENDIT): A randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet, 2004, 363, 925-931.
25. Skyler, J. S., Marks, J. B.: Immune intervention in type I diabetes mellitus. Diabetes Rev., 1993, 1, 15-42.
26. Fuchtenbusch, M., Rabl, W., Grassl, B. és mtsai: Delay of type I diabetes in high risk first degree relatives by parenteral antigen administration. Diabetologia, 1998, 41, 536-541. (Pubitemid 28206823)
27. DPT-1 Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med., 2002, 346, 1685-1691.
28. Skyler, J. S., Krischer, J. P., Wolfsdorf, J. és mtsai: Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care, 2005, 28, 1068-1076. (Pubitemid 40616615)
29. Harrison, L. C., Honeyman, M. C., Steele, C. E. és mtsai: Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care, 2004, 27, 2348-2355. (Pubitemid 39281384)
30. Nanto-Salonen, K., Kupila, A., Simell, S. és mtsai: Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring risk of disease: a double-blind, randomised controlled trial. Lancet, 2008, 372, 1746-1755.
31. Chatenoud, L.: Les anticorps monoclonaux anti-CD3: une premiere etape vers un traitement du diabete insulino-dependant d'ori-gine auto-immune. Med. Sci. (Paris), 2006, 22, 5-6. (Pubitemid 43128203)
32. Raz, I., Elias, D., Avron, A. és mtsai: Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II. Trial. Lancet, 2001, 358, 1749-1753. (Pubitemid 33152998)
33. Schloot, N., Meierhoff, G., Lengyel, C. és mtsai: Effect of heat-shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent onset diabetes mellitus type 1. Diabetes Metab. Res. Rev., 2007, 23, 276-285. (Pubitemid 46851468)
34. Chatenaud, L., Bluestone, J.: CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol., 2007, 7, 622-632. (Pubitemid 47123550)
35. Herold, K. C., Gitelman, S. E., Masharani, U. és mtsai: A single course of anti-CD3 monoclonal antibody OKT3 results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes, 2005, 554, 1753-1769.
36. Herold, K. C., Gitelman, S. E., Greenbaum, C.: Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years. Clin. Immunol., 2009, 132, 166-173.
37. Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H. és mtsai: Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab, B-lymphocyte depletion, and preservation of beta cell function. N. Engl. J. Med., 2009, 361, 2143-2152.
38. Orban, T., Farkas, K., Jalahej, H. és mtsai: Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J. Autoimmun. 2010, 34, 408-415.
39. Orbán T.: Személyes közlés. 2010.